Brady Huggett is features editor at The Transmitter, where he writes and edits features and long-form projects. He is also the creator and host of the “Synaptic” podcast. Before joining The Transmitter in 2022, he served as business editor at Nature Biotechnology, and prior to that was the managing editor of BioWorld.
Brady Huggett
Features editor
The Transmitter
From this contributor
Releasing the Hydra with Rafael Yuste
By
Brady Huggett, Shaena Montanari
4 April 2025 | 10 min read
Timothy Ryan on his pivotal switch from studying particle physics to decoding synaptic transmission
By
Brady Huggett
1 October 2024 | 70 min listen
Education
- M.A. in creative writing, The New School
- M.A. in journalism, University of North Carolina at Chapel Hill
- B.S. in biology from Wake Forest University in Winston-Salem, North Carolina
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read